Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Shunji, Kamigaki"'
Autor:
Shin Takahashi, Nobuaki Sato, Kouji Kaneko, Norikazu Masuda, Masaaki Kawai, Hisashi Hirakawa, Tadashi Nomizu, Hiroji Iwata, Ai Ueda, Takashi Ishikawa, Hiroko Bando, Yuka Inoue, Takayuki Ueno, Shinji Ohno, Makoto Kubo, Hideko Yamauchi, Masahiro Okamoto, Eriko Tokunaga, Shunji Kamigaki, Kenjiro Aogi, Hideaki Komatsu, Masahiro Kitada, Yasuaki Uemoto, Tatsuya Toyama, Yutaka Yamamoto, Toshinari Yamashita, Takehiro Yanagawa, Hiroko Yamashita, Yoshiaki Matsumoto, Masakazu Toi, Minoru Miyashita, Takanori Ishida, Fumiyoshi Fujishima, Satoko Sato, Takuhiro Yamaguchi, Fumiaki Takahashi, Chikashi Ishioka
Publikováno v:
Translational Oncology, Vol 48, Iss , Pp 102060- (2024)
The TP53 signature is considered a predictor of neoadjuvant chemotherapy (NAC) response and prognostic factor in breast cancer. The objective of this study was to confirm TP53 signature can predict pathological complete response (pCR) and prognosis i
Externí odkaz:
https://doaj.org/article/74d2b36fc35b41b88125efdc9ac30b6a
Autor:
Jun Yamamura, Shunji Kamigaki, Junya Fujita, Hiroki Osato, Hironobu Manabe, Yumiko Tanaka, Wataru Shinzaki, Yukihiko Hashimoto, Yoshifumi Komoike
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background The initial therapeutic strategy for hormone receptor-positive (HR+), HER2-negative (HER2-) breast cancer is based on the first metastatic site; however, little evidence is available regarding the influence of metastatic distribut
Externí odkaz:
https://doaj.org/article/b6e83e2655da4285bef4a56e915ef03d
Autor:
Yukiko Miyamura, Shunji Kamigaki, Jun Yamamura, Yukihiko Hahimot, Hironobu Manabe, Yoshifumi Komoike, Toshikazu Ito, Junya Fujita, Yumiko Tanaka, Hiroki Osato, Wataru Shinzaki
Publikováno v:
Breast Disease. 41:109-114
BACKGROUND: Current guidelines define primary and secondary endocrine resistance according to the periods of adjuvant endocrine therapy (adj-ET); however, the relationship between adj-ET period and endocrine resistance remains unclear. OBJECTIVE: We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e5d3df542436dc73bcff8499b49de60
https://doi.org/10.3233/bd-210027
https://doi.org/10.3233/bd-210027
Autor:
Takayuki Ueno, Norikazu Masuda, Shunji Kamigaki, Takashi Morimoto, Shigehira Saji, Shigeru Imoto, Hironobu Sasano, Masakazu Toi
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 4, p 984 (2019)
Endocrine therapy is an essential component in the curative treatment of hormone receptor (HR)-positive breast cancer. To improve treatment efficacy, the addition of metronomic chemotherapy has been tested and shown to improve therapeutic effects. To
Externí odkaz:
https://doaj.org/article/518ee13d651445c696235576f7231416
Autor:
Takayuki Ueno, Satoshi Morita, Shunji Kamigaki, Sunao Tanaka, Norikazu Masuda, Masakazu Toi, Hitoshi Tsuda, Masafumi Kurosumi, Yoshiki Mikami, Takashi Morimoto, Futoshi Akiyama
Publikováno v:
Cancer Medicine
Neoadjuvant endocrine therapy has been reported to decrease tumor size, which leads to increased breast conservation rates. To improve the clinical response, metronomic chemotherapy with endocrine therapy is a promising strategy. A multicenter phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c0b2d457c5e5050a81aff22d39fa716
https://doi.org/10.1002/cam4.1516
https://doi.org/10.1002/cam4.1516
Autor:
Norikazu Masuda, Shigehira Saji, Masakazu Toi, Shigeru Imoto, Hironobu Sasano, Takayuki Ueno, Shunji Kamigaki, Takashi Morimoto
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 4, p 984 (2019)
International Journal of Molecular Sciences
Volume 20
Issue 4
International Journal of Molecular Sciences
Volume 20
Issue 4
Endocrine therapy is an essential component in the curative treatment of hormone receptor (HR)-positive breast cancer. To improve treatment efficacy, the addition of metronomic chemotherapy has been tested and shown to improve therapeutic effects. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6efc1ddc227f3961ad02c7cf9c8006d0
https://www.mdpi.com/1422-0067/20/4/984
https://www.mdpi.com/1422-0067/20/4/984
Autor:
Tetsuhiro Yoshinami, M Kagawa, Katsuhide Yoshidome, A Enami, Nobuki Matsunami, Noriyuki Masuda, Makiko Mizutani, T Nomura, E Shiba, Takashi Morimoto, Shunji Kamigaki, Tsutomu Takashima, Tomio Nakayama, Hiroyuki Yasojima, T Nishi, Y Kozuma
Publikováno v:
Cancer Research. 76:P1-10
Introduction Chemotherapy induced peripheral neuropathy (CIPN) is a major problem for patients who receive chemotherapy, and it sometimes deteriorate patients' QOL. Many CIPN prevention trials have been conducted, but no one succeeded to date. Object
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e540b5883170daa7b1ec6ed2f1320731
https://doi.org/10.1158/1538-7445.sabcs15-p1-10-26
https://doi.org/10.1158/1538-7445.sabcs15-p1-10-26
Publikováno v:
In Vivo. 32
BACKGROUND/AIM Patients with de novo stage IV and recurrent metastatic breast cancer are often treated with the same strategies, although the difference in prognostic outcomes remains unclear. The objective of this retrospective chart review study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0252dc0acb02fd500318bea7c5a3fc7
https://doi.org/10.21873/invivo.11245
https://doi.org/10.21873/invivo.11245
Publikováno v:
In vivo (Athens, Greece). 32(2)
Background/Aim: Patients with de novo stage IV and recurrent metastatic breast cancer are often treated with the same strategies, although the difference in prognostic outcomes remains unclear. The objective of this retrospective chart review study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0b7ebe8f8d3b69418a7216590904c9c0
https://pubmed.ncbi.nlm.nih.gov/29475920
https://pubmed.ncbi.nlm.nih.gov/29475920
Autor:
Rumi, Sumida, Hiroshi, Imamura, Setsuko, Anami, Natsuko, Takada, Yuuko, Fujita, Yukie, Inui, Chihiro, Iseki, Keiko, Hamaguchi, Emiko, Yamamoto, Chika, Fujii, Misako, Fujino, Shunji, Kamigaki, Tomono, Kishimoto, Ryouhei, Kawabata, Hiroshi, Furukawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 38(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ce96cce6763623596a55a6bb34d54a9
https://pubmed.ncbi.nlm.nih.gov/28676600
https://pubmed.ncbi.nlm.nih.gov/28676600